Page 23 - Bharat Biotech

India Coronavirus Dispatch: Nod to Covaxin raises many eyebrows

Other vaccines being developed in India, dangerous conspiracy theories, private hospitals keen on jumping in-news relevant to India's fight against Covid-19

India's Covid-19 vaccination challenge needs a private sector helping hand

The media and opposition figures have justifiably asked why Bharat Biotech's candidate was approved at the same time as AstraZeneca's, when it hasn't even finished or published results from Stage III

Best of BS Opinion: Covid-19 vaccine, promise of techno-nationalism & more

Here's a selection of Business Standard opinion pieces for the day

Covid-19 vaccine: I am not worried about the efficacy, says Jacob John

I would go for Bharat Biotech's Covaxin and not Covishield, and that is my personal judgment, the former head of Centre for Advanced Research in Virology at ICMR says

Bharat Biotech chief takes on Serum Institute in Covid-19 vaccine war

Krishna Ella turns the tables on critics, questions approval granted to Oxford-Astra vaccine

A shot at transparency

Approval to Covaxin raises many questions

Covaxin: Science, not pride will help India build trust in this vaccine

The hasty nod for Bharat Biotech's Covaxin, developed in collaboration with the ICMR and National Institute of Virology, has raised eyebrows in the scientific and healthcare communities

World's biggest Covid-19 vaccination programme set to begin in India: PM

Lauding the people behind this Made in India initiative, Modi said: "The country is proud of the contributions of its scientists and technicians."

Bharat Biotech aims to make 700 million doses of Covid-19 vaccine in 2021

The vaccine candidate, Covaxin, received emergency use approval from India's drugs regulator on Sunday

Bharat Biotech hits outs at critics, says carried out '200% honest' trials

Questions were raised by industry experts and opposition parties on the emergency approval to its coronavirus vaccine without publication of efficacy data

Bharat Biotech setting up four vaccine manufacturing facilities

Bharat Biotech on Monday said the firm is setting up four vaccine manufacturing facilities with a combined capacity of 700 million doses per annum

India Coronavirus Dispatch: Those already infected may still need shots

How was the nationwide dry run carried out, the next steps in the vaccine roll-out, findings from a large-scale UK study on the new variant, and more-news relevant to India's fight against Covid-19

India gets Covid-19 vaccine: DCGI nod for Serum Institute, Bharat Biotech

Health Minister Harsh Vardhan termed it a 'watershed moment in India's battle against Covid-19'

Bharat Biotech: A journey that started with a scientist's return to India

First a scientist and then a businessman, founder chairman Krishna Ella quit his faculty position at the Medical University of South Carolina in Charleston, United States, in 1996 to return to India

Serum, Bharat Biotech vaccines get restricted use approval from DCGI

While the Oxford-AstraZeneca vaccine made by Serum Institute here has 70.42% efficacy, Bharat Biotech's still does not have efficacy data as trials are underway in India

Controversy around Bharat Biotech's Covaxin approval without efficacy data

Bharat Biotech's Covaxin is based on a whole inactivated virus platform, an old technology which is used to make vaccines given to infants

ICMR says clinical trial data show Bharat Biotech's Covaxin is 'safe'

Indian Council of Medical Research (ICMR) on Sunday said data generated through pre-clinical studies and various phases of clinical trial shows Covaxin is 'safe'

All risks paid off, India proud: SII, Bharat Biotech on Covid vaccine nod

With the government approving two Covid-19 vaccines for emergency use, Serum Institute said it is ready to roll out Covishield vaccine in India in the coming weeks

Congress not proud of anything Indian: Nadda over vaccine approval concerns

"Congress and the Opposition is not proud of anything Indian. They should introspect about how their lies on the Covid-19 vaccine will be used by vested interest groups for their own agendas," he said

Congress leaders divided over DCGI approval to Bharat Biotech's Covaxin

Some Congress leaders raised serious concern over the grant of approval to Bharat Biotech's Covid-19 vaccine for restricted use, saying it is "premature" and can prove dangerous